Galapagos (GLPG)
(Delayed Data from NSDQ)
$32.56 USD
-0.32 (-0.97%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $32.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Galapagos NV's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GLPG 32.56 -0.32(-0.97%)
Will GLPG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GLPG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GLPG
Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
GLPG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
Other News for GLPG
Galapagos (GLPG) Secures RMAT Status for Innovative Cancer Therapy
Galapagos granted RMAT designation to GLPG5101 by FDA
Galapagos (GLPG) Downgraded by Deutsche Bank with New Price Target
Galapagos (GLPG) Downgraded to Sell Amid Uncertainty
Deutsche Bank downgrades Galapagos to Sell amid 'too much uncertainty'